Hospital noise exposure: a systematic review of levels, sources, and effects on patients and staff
Abstract
Introduction: Noise is often underestimated as a hospitalrelated hazard. This systematic review aimed to assess noise levels in hospitals, their sources, and the associated physiological and psychological impacts on the hospital community.
Materials and methods: A literature search was conducted through PubMed, ProQuest, Ovid, and Scopus without language or date restrictions. Studies in all languages were considered, non-English articles were assessed using machine translation, although none met the inclusion criteria. This review was registered in PROSPERO under registration number CRD42025112689. Quantitative, qualitative, and mixed-method study designs that assessed hospital noise levels, sources, or effects were included. Risk of bias was appraised using the Joanna Briggs Institute (JBI) critical appraisal tools based on study designs, and the data were synthesised narratively.
Results: Eighteen studies were included in the qualitative synthesis, which consisted of cross-sectional (n=10), cohort (n=7), and qualitative (n=1) designs conducted across various countries. Noise levels frequently exceeded World Health Organization (WHO) limits, with mean equivalent levels (LAeq) ranging from 43 to 75.8 dB(A) and peak levels (LAFmax) reaching 100 dB(A). Intensive Care Units (ICUs) and Emergency Departments (EDs) were consistently reported as the noisiest departments. The physiological and psychological impacts experienced by the hospital community included stress, sleep…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 10 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.